We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

152 hedge funds and large institutions have $1.05B invested in Immunogen Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $746M → $1.05B (+$307M)

21% more call options, than puts

Call options by funds: $2.52M | Put options by funds: $2.08M

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

4% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 46

1% more funds holding

Funds holding: 151 → 152 (+1)

Holders
152
Holders Change
+1
Holders Change %
+0.66%
% of All Funds
3.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
48
Reduced
46
Closed
22
Calls
$2.52M
Puts
$2.08M
Net Calls
+$434K
Net Calls Change
-$965K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$30.8M
2
BBA
Baker Bros. Advisors
New York
+$11.1M
3
PA
Pinnacle Associates
New York
+$6.72M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.66M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.7M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$18.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.5M
3
State Street
State Street
Massachusetts
-$7.46M
4
BIM
Bogle Investment Management
Massachusetts
-$4.69M
5
Renaissance Technologies
Renaissance Technologies
New York
-$4.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
ClearBridge Investments
1
ClearBridge Investments
New York
$194M -$2.07M -168,507 -1%
Primecap Management
2
Primecap Management
California
$175M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$86.7M +$5.66M +459,957 +8%
O
4
OrbiMed
New York
$82.7M +$30.8M +2,501,647 +70%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$82.5M -$14.5M -1,180,472 -16%
BBA
6
Baker Bros. Advisors
New York
$60.4M +$11.1M +904,405 +25%
BFA
7
BlackRock Fund Advisors
California
$42.5M -$1.83M -148,447 -5%
State Street
8
State Street
Massachusetts
$35.5M -$7.46M -606,203 -19%
BIT
9
BlackRock Institutional Trust
California
$29.3M +$1.33M +108,187 +5%
PA
10
Pinnacle Associates
New York
$24M +$6.72M +545,784 +45%
Norges Bank
11
Norges Bank
Norway
$20.8M – – –
Wells Fargo
12
Wells Fargo
California
$19.5M -$181K -14,683 -1%
Northern Trust
13
Northern Trust
Illinois
$13.8M +$331K +26,931 +3%
Bank of America
14
Bank of America
North Carolina
$13.4M +$250K +20,285 +2%
Franklin Resources
15
Franklin Resources
California
$12.8M – – –
Morgan Stanley
16
Morgan Stanley
New York
$12.1M -$535K -43,478 -5%
Invesco
17
Invesco
Georgia
$11.5M -$1.48M -119,847 -12%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$8.5M +$1.51M +122,724 +24%
RJA
19
Raymond James & Associates
Florida
$8.35M +$271K +21,990 +4%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$7.99M -$45.9K -3,730 -0.6%
Prudential Financial
21
Prudential Financial
New Jersey
$6.78M +$911K +74,000 +17%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$6.39M +$34.8K +2,829 +0.6%
Macquarie Group
23
Macquarie Group
Australia
$5.83M – – –
TCIM
24
TIAA CREF Investment Management
New York
$4.09M -$131K -10,627 -3%
Deutsche Bank
25
Deutsche Bank
Germany
$3.99M -$3.17M -257,812 -47%
1
2 3 4 5

IMGN Hedge Fund Activity: Q4 2015 in Review

152 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2015, worth a combined $1.05B — up 41% from $746M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new IMGN positions and 22 closed out — a net gain of 1 holder — while 48 added to existing stakes and 46 trimmed.

The largest buyer was OrbiMed, adding an estimated $30.8M. The largest seller was Millennium Management, cutting an estimated $18.8M.

  • 152 institutional investors held Immunogen Inc (IMGN) as of Q4 2015, up from 151 in Q3 2015.
  • Funds reported $1.05B of Immunogen Inc stock for Q4 2015, up 41% quarter-over-quarter.
  • 23 funds opened new Immunogen Inc positions in Q4 2015 and 22 closed out, a net change of +1 holder.
  • The largest Immunogen Inc buyer in Q4 2015 was OrbiMed, an estimated $30.8M added.
  • The largest Immunogen Inc seller in Q4 2015 was Millennium Management, an estimated $18.8M sold.

Based on aggregated 13F filings for Q4 2015.